Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis. (Q48430924)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

J. Bruno Montoro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Ramon Orriols

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Rosana Hernando

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

María Estrella Drobnic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Adelaida Ferrer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Pilar Suñé

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

9 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Pharmacy

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

644-650

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684355%20AND%20SRC:MED&resulttype=core&format=json

Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Standardisation of spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Inhaled steroids in patients with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Inhaled fluticasone in bronchiectasis: a 12 month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Inhaled steroids improve quality of life in patients with steady-state bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Glucocorticoids and invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Cystic fibrosis in Spain: high frequency of mutation G542X in the Mediterranean coastal area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-012-9659-6

Antibiotic susceptibility testing by a standardized single disk method

21 January 2018

1 reference

12 December 2020

Inhaled corticosteroids in obstructive airway disease

1 reference

12 December 2020

Inhaled Fluticasone Reduces Sputum Inflammatory Indices in Severe Bronchiectasis

1 reference

12 December 2020

[Guideline for the use of inhaled drugs. The Working Group of SEPAR: the Nursing Area of the Sociedad Española de Neumología y Cirugía Torácica]

1 reference

12 December 2020

Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination

1 reference

12 December 2020

Bronchial epithelial cell-cytokine interactions in airway inflammation

1 reference

12 December 2020

Inhaled steroids for bronchiectasis

1 reference

12 December 2020

Microscopic and baceriologic analysis of expectorated sputum

1 reference

12 December 2020